CAMBRIDGE, Mass., Sept. 8, 2010 (GLOBE NEWSWIRE) -- Infinity Pharmaceuticals, Inc. (Nasdaq:INFI) will be presenting at the Rodman & Renshaw Annual Global Investment Conference in New York on Wednesday, September 15, 2010 at 11:40 a.m. EDT.
In addition, Infinity will be presenting at the UBS Global Life Sciences Conference in New York on Wednesday, September 22, 2010 at 11:30 a.m. EDT. Adelene Q. Perkins, president and chief executive officer, will provide a corporate overview at both conferences.
A live webcast of Infinity's presentations will be accessible on the "investors/media" section of the company's website, , and will be available for 30 days following the event.
About Infinity Pharmaceuticals, Inc.
Infinity is an innovative cancer drug discovery and development company seeking to discover, develop, and deliver to patients best-in-class medicines for difficult-to-treat diseases. Infinity combines proven scientific expertise with a passion for developing novel small molecule drugs that target emerging disease pathways. Infinity's programs in the inhibition of the Hsp90 chaperone system, the Hedgehog pathway, fatty acid amide hydrolase and phosphoinositide-3-kinase are evidence of its innovative approach to drug discovery and development. For more information on Infinity, please refer to the company's website at http://www.infi.com.
CONTACT: Infinity Pharmaceuticals, Inc. Jaren Irene Madden 617-453-1336 Jaren.Madden@infi.com http://www.infi.com
